97
Participants
Start Date
March 18, 2021
Primary Completion Date
January 30, 2024
Study Completion Date
January 30, 2024
Posoleucel (ALVR105)
Administered as 2-4 milliliter infusion, visually identical to placebo
Placebo
Administered as 2-4 milliliter infusion, visually identical to Posoleucel (ALVR105)
Roswell Park Comprehensive Cancer Center, Buffalo
Children's Hospital of Philadelphia (CHOP), Philadelphia
Children's National Medical Center, Washington D.C.
Johns Hopkins Medicine, Baltimore
Virginia Commonwealth University, Richmond
Northside Hospital, Atlanta
University of Miami, Miami
Moffitt, Tampa
Ohio State University Medical Center (OSUMC), Columbus
University Hospitals Cleveland Medical Center, Cleveland
Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
University of Minnesota, Minneapolis
Northwestern Memorial Hospital, Chicago
Children's Mercy Hospital - Kansas City, Kansas City
University of Kansas Cancer Center, Kansas City
University of Nebraska Medical Center, Omaha
The University of Texas Southwestern Medical Center, Dallas
Children's Hospital of Los Angeles, Los Angeles
City of Hope National Medical Center, Duarte
Oregon Health & Science University, Portland
Fred Hutchinson Cancer Research Center, Seattle
Yale University School of Medicine - Yale Cancer Center, New Haven
Dana-Farber Cancer Institute, Boston
Massachusetts General Hospital, Boston
Hackensack University Medical Center, Hackensack
CHU de Lille - Hopital Claude Huriez, Lille
CHU de Nantes - Hôtel-Dieu, Nantes
AP-HP Hopital Saint-Louis, Paris
HCL Centre Hospitalier Lyon Sud, Pierre-Bénite
IUCT-Oncopole, Toulouse
Azienda Ospedaliero-Universitaria Careggi, Florence
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan
IRCCS Ospedale San Raffaele, Milan
Ospedale Pediatrico Bambino Gesù, Roma
Fondazione Policlinico Universitario A. Gemelli IRCCS - Universita Cattolica del Sacro Cuore, Rome
Istituto Clinico Humanitas, Rozzano
Azienda Ospedaliera Universitaria Integrata Verona-Ospedale Borgo Trento, Verona
Chonnam National University Hwasun Hospital, Jeongnam
Asan Medical Center, Seoul
Pusan National University Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Hospital Clinic Barcelona, Barcelona
Hospital Universitario La Paz, Madrid
Hospital Regional Universitario de Malaga, Málaga
Hospital Universitari i Politecnic La Fe, Valencia
Karolinska University Hospital, Stockholm
University Hospitals Bristol NHS Foundation Trust, Bristol
Queen Elizabeth University Hospital - Glasgow, Glasgow
Great Ormond Street Hospital for Children, London
Hammersmith Hospital, London
The Royal Marsden NHS Foundation Trust, London
University College London Hospital, London
Nottingham University Hospitals, Nottingham
Lead Sponsor
AlloVir
INDUSTRY